Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder: A Target Trial Emulation Study

NCT07032337 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07032337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07032337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder: A Target Trial Emulation Study
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
December 31, 2022
Enrollment
2,985 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuromyelitis optica spectrum disorder (nmosd)